Sanofi (SNY) P/S (2002 - 2026)
Sanofi (SNY) P/S from Jul 1, 2002 to Jul 21, 2026. The TTM Sanofi (SNY) P/S is 1.90. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Sanofi (SNY)
| Year | P/S | Change |
|---|---|---|
| 2026 | 1.90 | -13.35% |
| 2025 | 2.19 | -15.94% |
| 2024 | 2.61 | +2.49% |
| 2023 | 2.55 | -1.24% |
| 2022 | 2.58 | -6.66% |
| 2021 | 2.76 | -2.00% |
| 2020 | 2.82 | -6.03% |
| 2019 | 3.00 | +16.05% |
| 2018 | 2.58 | -3.38% |
| 2017 | 2.68 | -7.31% |
| 2016 | 2.89 | -4.55% |
| 2015 | 3.02 | +11.76% |
| 2014 | 2.71 | -15.42% |
| 2013 | 3.20 | +19.37% |
| 2012 | 2.68 | +28.81% |
| 2011 | 2.08 | +4.31% |
| 2010 | 1.99 | -15.95% |
| 2009 | 2.37 | +20.31% |
| 2008 | 1.97 | -0.17% |
| 2007 | 1.98 | -12.42% |
| 2006 | 2.26 | +18.27% |
| 2005 | 1.91 | +9.61% |
| 2004 | 1.74 | +6.09% |
| 2003 | 1.64 | +24.18% |
| 2002 | 1.32 | N/A |
Comparison Sanofi (SNY) P/S with competitors
Sanofi (SNY) P/S is 1.90.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -69.75% |
| NVO | Novo Nordisk | 0.66 | -65.18% |
| GRFS | Grifols SA | 0.67 | -64.70% |
| AMRN | Amarin Corp | 1.39 | -26.88% |
| SCLX | Scilex Holding Company | 1.92 | +0.74% |
| PFE | Pfizer Inc | 2.18 | +14.84% |
| BMY | Bristol-Myers Squibb Company | 2.40 | +26.20% |
| BIIB | Biogen Inc | 2.93 | +54.13% |
| GSK | GSK Plc | 3.22 | +69.60% |
| MRK | Merck & Co Inc | 4.54 | +138.62% |
| AZN | Astrazeneca plc | 4.58 | +141.19% |
| NVS | Novartis AG | 5.07 | +166.71% |
| AMGN | AMGEN Inc | 5.15 | +170.92% |
| GILD | Gilead Sciences Inc | 5.43 | +185.64% |
| JNJ | Johnson & Johnson | 6.34 | +233.52% |
| ABBV | Abbvie Inc | 7.15 | +276.13% |
| LLY | Lilly(Eli) & Company | 14.28 | +651.20% |